How a pharma giant prioritised billions in profit over developing a crucial TB vaccine

Tuberculosis remains a ‘poor’ disease that mostly afflicts those living in developing countries.

Anna Maria Barry-Jester, ProPublica

· Oct 09, 2023 · 07:30 pm